Voluntary isn't working
By Marcy Darnovsky,
Modern Healthcare
| 04. 13. 2009
Recent events show need for regulation of assisted reproduction
Each year, assisted reproduction quietly helps thousands of people in their quest for children biologically related to them. But the fertility field has been far from quiet of late. In recent weeks, two scandals burst into the headlines
The first stories about the Southern California octuplets, in late January, focused on the novelty and details of their birth. But shock and then outrage quickly followed as news of the mother's circumstances and the fertility doctor's recklessness emerged. Entertainment news has yet to tire of the story; a more sober conversation about the need for additional policy and oversight is also simmering.
A few weeks later, the Wall Street Journal reported that another Los Angeles-area fertility clinic had begun advertising the "pending availability" of embryo screening to select for hair color, eye color and even skin tone. As that story bubbled into network and cable news, it elicited a reaction similar to the one surrounding the octuplets: What's going on here? How can irresponsible fertility doctors get away with this sort of thing?
These questions are not being asked only by...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...